Technology | Advanced Visualization | February 08, 2019

Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

Advanced visualization software includes new applications for MRI, cardiology and endoscopy

Fujifilm Launches Latest Synapse 3D Version at HIMSS 2019

The new Intravoxel Incoherent Motion (IVIM) MR application in Synapse 3D

February 7, 2019 — Fujifilm Medical Systems U.S.A. will debut the latest version of its Synapse 3D solution at the Healthcare Information and Management Systems Society (HIMSS) global conference and exhibition, Feb. 11-15 in Orlando, Fla. The latest Synapse 3D Advanced Visualization software introduces five new applications, in addition to its current 50 clinical applications, that will be available for demonstration.

An enterprise-wide solution designed to quickly perform advanced visualization workflows and access 3-D rendered images, Synapse 3D boasts a total of 55 advanced applications, including five newly launched tools:

  • Breast Analyzer MR — A multi-faceted application that analyzes breast tumors in magnetic resonance imaging (MRI) and generates Breast Imaging-Reporting and Data System (BI-RADS) reports. It includes kinetic curves for wash-in and wash-out, and subtraction of pre- and post-contrast. The tool also performs a variety of measurements including distance from the nipple, distance from the skin, distance from the chest wall and tumor volume.
  • Delayed Enhancement MR — Designed with input from cardiologists, this application analyzes myocardial viability, provides delayed enhancement area and volume measurements, and displays the enhanced area overlaid in the bulls-eye map.
  • Endoscopic Simulator — With simulation now a key tool in training of physicians, this application was designed specifically for laparoscopic surgery simulation. It simulates inflation of the abdomen, port placement and positioning. The tool also offers the capability to automatically segment vessels, skin, bone, pancreas, spleen and tumors.
  • Intravoxel Incoherent Motion (IVIM) MR — The tool uses diffusion-weighted images to provide quantitative data from tissue microcapillary perfusion. It also automatically displays an ADC map, eADC map, D map, D* map and f map.
  • Prostate Viewer MR — A robust application to support prostate cancer diagnosis, this tool analyzes prostate gland tumors and generates Prostate Imaging-Reporting and Data System (PI-RADS) reports. It measures both diameter and volume of the prostate gland and lesions. It also features an array of viewing tools for comparative observation of multiple series, T2, ADC, DWI, DCE and time intensity curves.

In addition to these new applications, Synapse 3D delivers a comprehensive suite of applications consisting of general-use and specialty options for advanced image visualization and analysis. The software features Image Intelligence recognition technology that helps optimize processing capabilities, providing increased confidence in image assessment for providers. Designed with extensive clinical input, Synapse 3D incorporates intuitive, logical workflows that guide users to efficient and accurate results that can lead to improved patient outcomes.

For more information: www.fujimed.com

Related Content

ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.
Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Cianna Medical featured its wire-free marker system on the exhibit floor of the breast imaging symposium in Hollywood, Fla.

Feature | Breast Imaging | April 24, 2019 | By Greg Freiherr
Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast.
GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...
Graphic courtesy of Pixabay

Graphic courtesy of Pixabay

Feature | Artificial Intelligence | April 22, 2019 | By Greg Freiherr
...
HHS Extends Comment Period for Proposed Electronic Health Information Interoperability Rules
News | Electronic Medical Records (EMR) | April 19, 2019
The U.S. Department of Health and Human Services (HHS) is extending the public comment period by 30 days for two...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.